Windtree Therapeutics and Lee’s Pharmaceutical (HK) Limited Enter Into Exclusive License and Collaboration Agreement for Development and Commercialization of KL4 Surfactant Technology Platform in Asia
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.leespharm.com/wp-content/uploads/2019/05/LeesPharma_Licensing_Agreement_PR_FINAL_13062017.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (2)
Alternatively, you can try searching for similar contracts: